-
Your prediction
Pros and Cons of Advanced Proteome Therapeutics in the next few years
Pros
Cons
Performance of Advanced Proteome Therapeutics vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Advanced Proteome Therapeutics | - | - | - | - | - | - | - |
| Satellos Bioscience Inc. | -2.110% | 14.851% | 16.000% | -18.596% | 14.851% | 151.354% | - |
| Larimar Therapeutics Inc. | -0.690% | -13.855% | -8.333% | -23.936% | -13.855% | -23.529% | -82.936% |
| Vaxart Inc. | 22.220% | 17.857% | 17.857% | -59.209% | 17.857% | -64.247% | -93.889% |
News
Stock Market Today, Jan. 8: Nvidia Slides as AI Demand Forecasts Top $500 Billion
Nvidia (NASDAQ:NVDA), a GPU and AI solutions leader, closed Thursday's session at $185, down 2.17%. Nvidia IPO'd in 1999 and has grown an astounding 450,934% since going public. Trading volume
Penguin Solutions: The Deep-Value AI Play You’ve Been Looking For
Penguin Solutions (NASDAQ: PENG) could be the deep value AI play you’ve been looking for. It's currently trading at pennies on the dollar relative to long-term forecasts—forecasts that may be
Jensen Huang Just Delivered Brilliant News to Nvidia Investors for 2026
Nvidia (NASDAQ: NVDA) has been an artificial intelligence (AI) champion since the start of the AI boom. The company got into the space early, focusing the design of its chips to suit this


